KevinMD November 15, 2024
Lecia V. Sequist, MD, MPH

I recently encountered a new patient, a seemingly healthy 25-year-old man who had just graduated from college and was working his first job. He was not a tobacco user and had no medical diagnoses, but shoulder and abdominal pain brought him to Mass General Brigham. After a series of tests, the diagnosis was clear: stage IV lung cancer.

As a lung cancer oncologist who has treated patients for 20 years, I’ve seen major changes in my clinic. Treatments have improved dramatically, and patients are living longer, but survival statistics around stage IV lung cancer still paint a bleak picture: only about 10 percent of patients survive beyond five years. When I was in medical school, the average age of lung...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider
How postmortem brain research is changing autism science [PODCAST]
How a nurse’s journey through trauma inspires hope and kindness
Heart surgeons may deliver better outcomes during stressful procedures
Smartwatches reveal insights into psychiatric illnesses and genetic links
Digital therapeutics: Exploring the road to commercialization across international markets

Share This Article